rs42531

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000089.4(COL1A2):​c.2565+233G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.28 in 545,616 control chromosomes in the GnomAD database, including 22,970 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 5258 hom., cov: 31)
Exomes 𝑓: 0.30 ( 17712 hom. )

Consequence

COL1A2
NM_000089.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.00500

Publications

8 publications found
Variant links:
Genes affected
COL1A2 (HGNC:2198): (collagen type I alpha 2 chain) This gene encodes the pro-alpha2 chain of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, recessive Ehlers-Danlos syndrome Classical type, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for the alpha1 chain of type I collagen (COL1A1) reflecting the different role of alpha2 chains in matrix integrity. Three transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
COL1A2 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, arthrochalasia type, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Illumina, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • osteogenesis imperfecta
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • osteogenesis imperfecta type 1
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • osteogenesis imperfecta type 4
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Ehlers-Danlos syndrome, arthrochalasia type
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • Ehlers-Danlos syndrome, cardiac valvular type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, PanelApp Australia, Orphanet, G2P
  • combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen, Ambry Genetics
  • Ehlers-Danlos/osteogenesis imperfecta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • high bone mass osteogenesis imperfecta
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 7-94423351-G-A is Benign according to our data. Variant chr7-94423351-G-A is described in ClinVar as Benign. ClinVar VariationId is 1269568.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.307 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL1A2NM_000089.4 linkc.2565+233G>A intron_variant Intron 40 of 51 ENST00000297268.11 NP_000080.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL1A2ENST00000297268.11 linkc.2565+233G>A intron_variant Intron 40 of 51 1 NM_000089.4 ENSP00000297268.6
COL1A2ENST00000481570.5 linkn.881G>A non_coding_transcript_exon_variant Exon 1 of 8 2
COL1A2ENST00000497316.5 linkn.*233G>A downstream_gene_variant 2

Frequencies

GnomAD3 genomes
AF:
0.237
AC:
36000
AN:
151834
Hom.:
5260
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0613
Gnomad AMI
AF:
0.283
Gnomad AMR
AF:
0.255
Gnomad ASJ
AF:
0.283
Gnomad EAS
AF:
0.256
Gnomad SAS
AF:
0.278
Gnomad FIN
AF:
0.378
Gnomad MID
AF:
0.255
Gnomad NFE
AF:
0.311
Gnomad OTH
AF:
0.233
GnomAD4 exome
AF:
0.296
AC:
116582
AN:
393662
Hom.:
17712
Cov.:
4
AF XY:
0.296
AC XY:
62360
AN XY:
210742
show subpopulations
African (AFR)
AF:
0.0564
AC:
627
AN:
11114
American (AMR)
AF:
0.250
AC:
4387
AN:
17538
Ashkenazi Jewish (ASJ)
AF:
0.294
AC:
3420
AN:
11618
East Asian (EAS)
AF:
0.263
AC:
6470
AN:
24614
South Asian (SAS)
AF:
0.283
AC:
12634
AN:
44652
European-Finnish (FIN)
AF:
0.363
AC:
7931
AN:
21824
Middle Eastern (MID)
AF:
0.244
AC:
408
AN:
1670
European-Non Finnish (NFE)
AF:
0.313
AC:
74496
AN:
238168
Other (OTH)
AF:
0.276
AC:
6209
AN:
22464
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
3982
7963
11945
15926
19908
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
398
796
1194
1592
1990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.237
AC:
35986
AN:
151954
Hom.:
5258
Cov.:
31
AF XY:
0.241
AC XY:
17927
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.0611
AC:
2535
AN:
41488
American (AMR)
AF:
0.256
AC:
3900
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.283
AC:
982
AN:
3470
East Asian (EAS)
AF:
0.255
AC:
1313
AN:
5146
South Asian (SAS)
AF:
0.277
AC:
1335
AN:
4820
European-Finnish (FIN)
AF:
0.378
AC:
3984
AN:
10546
Middle Eastern (MID)
AF:
0.248
AC:
73
AN:
294
European-Non Finnish (NFE)
AF:
0.311
AC:
21121
AN:
67918
Other (OTH)
AF:
0.230
AC:
485
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1303
2606
3908
5211
6514
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
376
752
1128
1504
1880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.265
Hom.:
741
Bravo
AF:
0.220
Asia WGS
AF:
0.232
AC:
805
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.0
DANN
Benign
0.39
PhyloP100
0.0050
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs42531; hg19: chr7-94052663; API